These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20438413)

  • 1. Theranostic and prognostic biomarkers: genomic applications in urological malignancies.
    Netto GJ; Epstein JI
    Pathology; 2010 Jun; 42(4):384-94. PubMed ID: 20438413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnostics in urologic malignancies: a work in progress.
    Netto GJ
    Arch Pathol Lab Med; 2011 May; 135(5):610-21. PubMed ID: 21526959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics and genomics progress in urothelial bladder cancer.
    Netto GJ
    Semin Diagn Pathol; 2013 Nov; 30(4):313-20. PubMed ID: 24342287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid-based marker approaches to urologic cancers.
    Veltri RW; Makarov DV
    Urol Oncol; 2006; 24(6):510-27. PubMed ID: 17138133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in urological malignancies].
    Kuriyama M
    Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular biology advances and perspectives in urology].
    Feria Bernal G; Arroyo Kuribreña JC
    Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Netto GJ
    Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel blood biomarkers of human urinary bladder cancer.
    Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
    Ohori M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic biomarkers in renal cell carcinoma.
    Jiang Z
    Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers for prostate cancer.
    Reynolds MA; Kastury K; Groskopf J; Schalken JA; Rittenhouse H
    Cancer Lett; 2007 Apr; 249(1):5-13. PubMed ID: 17303324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis and diagnostics of bladder cancer.
    Mitra AP; Cote RJ
    Annu Rev Pathol; 2009; 4():251-85. PubMed ID: 18840072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic markers as promising prognosticators for bladder cancer.
    Kim YK; Kim WJ
    Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathology of urological malignancies.
    Dorkin TJ; Robson CN; Neal DE
    J Pathol; 1997 Dec; 183(4):380-7. PubMed ID: 9496253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
    Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
    Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.